Department of Clinical Laboratory, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 1050001, Japan.
Department of Hematology, Toranomon Hospital, Tokyo, Japan.
Int J Hematol. 2024 May;119(5):573-582. doi: 10.1007/s12185-024-03727-x. Epub 2024 Feb 26.
The number of umbilical cord blood transplantation (U-CBT) procedures has been growing annually, but little research has been done on long-term immune recovery after U-CBT. Infection risk is high in U-CBT recipients, and this can be partially attributed to immature immunocompetent cells in umbilical cord blood. In this study, we analyzed lymphocyte subset (LST) number to determine the long-term recovery timeline. We included 36 U-CBT and 10 unrelated bone marrow transplantation (U-BMT) recipients who survived more than 2 years after transplantation, and followed them for up to 10 years post-transplant. Recovery kinetics in the early phase post-transplant was different for each LST. Recovery of CD19 B cells was faster after U-CBT than after U-BMT in the first 5 years after transplantation. Although CD4 T cells increased in the first several months after U-CBT, long-term cell count recovery was impaired in approximately 20% of patients. Thus, although the LST recovery pattern after U-CBT was unique, LST number recovery was statistically comparable between U-CBT and U-BMT past 5 years post-transplantation.
脐带血移植(U-CBT)的数量逐年增加,但对 U-CBT 后长期免疫恢复的研究甚少。U-CBT 受者感染风险较高,这在一定程度上可归因于脐带血中不成熟的免疫活性细胞。在这项研究中,我们分析了淋巴细胞亚群(LST)数量,以确定长期恢复时间线。我们纳入了 36 例 U-CBT 和 10 例无关供者骨髓移植(U-BMT)受者,这些受者在移植后存活超过 2 年,并在移植后长达 10 年进行随访。移植后早期 LST 的恢复动力学各不相同。在移植后 5 年内,U-CBT 后 CD19 B 细胞的恢复速度比 U-BMT 更快。尽管 U-CBT 后 CD4 T 细胞在前几个月增加,但约 20%的患者长期细胞计数恢复受损。因此,尽管 U-CBT 后 LST 恢复模式独特,但 U-CBT 和 U-BMT 移植后 5 年以上的 LST 数量恢复在统计学上无差异。